FDA Clears Prodesse’s ProFASTâ¢+ Assay To Identify Three Strains Of Influenza A, Including 2009 H1N1

How to reduce your risk of contracting swine flu:

Do not travel to areas known to be affected.

Minimize the amount of time spent on public transport especially aeroplanes.

Avoided crowded public places, especially those using recirculated air conditioned air

Wear a surgical grade face mask and ensure it is fitted correctly so that it covers your nose as well as your mouth.

Refrain from touching your mouth with your hands or fingers if they may have come into contact with surfaces contiminated with the virus.

Carefully wipe any surfaces that may have come into contact with carriers such as door handles, toilet flushers, work surfaces and telephones

FDA Clears Prodesse’s ProFASTâ¢+ Assay To Identify Three Strains Of Influenza A, Including 2009 H1N1

Gen-Probe Incorporated (Nasdaq: GPRO) announced that the U.S. Food and Drug Administration (FDA) has cleared for marketing Prodesse's ProFASTâ¢+ assay, making it the only FDA-cleared molecular diagnostic test to simultaneously detect and differentiate three common influenza A virus subtypes seasonal A/H1, seasonal A/H3, and 2009 H1N1. "FDA clearance of our ProFAST+ assay is important for public health, as the test enables physicians to accurately differentiate among influenza A subtypes that have different antiviral susceptibilities," said Carl Hull, Gen-Probe's president and CEO... (Source: Health News from Medical News Today)

Comments are closed.